Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HHS vs STRR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

STRR Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–4 Matrix Metrics)

STRR Overall Winner 6-Pillar Tally: HHS 2 – 3 STRR (1 Tie) Matrix Metrics: HHS 4 – 5 STRR

As of Nov 16, 2026, Star Equity Holdings, Inc. (STRR) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas STRR carries 47.5/100 (HOLD) at $9.84 (8.8x Forward P/E, -2.6% operating margin).

  • Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. STRR 47.5/100 HOLD), STRR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-2.6% vs. -3.2% operating margin) and revenue trajectory (+54.6% vs. -1.7% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HHS vs STRR
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
TTM Revenue $155M
Forward P/E 14.3x
Beta / 30D Vol 0.49β · 46% Vol
Unified Composite Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.2 · SMA20: $3.95 · SMA50: $4.26
STRR NASDAQ Head-to-Head Winner
Star Equity Holdings, Inc. Common Stock
Services-Help Supply Services
$9.84
-0.56% 1D
Market Cap $37.3M
TTM Revenue $210M
Forward P/E 8.8x
Beta / 30D Vol 0.12β · 48% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 68.0 Fund 51.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.6 · SMA20: $9.62 · SMA50: $9.91

6-Pillar Scorecard Institutional Category Breakdown (HHS 2 – 3 STRR)

Columns: Metric · HHS · STRR
1. Valuation Multiples STRR
Forward P/E 14.3x 8.8x
Trailing P/E 14.3x 10.6x
PEG Ratio 1.19x 2.03x
EV / Revenue 0.3x 0.3x
2. Growth & Scale STRR
Revenue Growth (YoY) -1.7% +54.6%
Earnings Growth (YoY) -90.3% -21.6%
TTM Revenue (USD) $155M $210M
Market Cap $30.0M $37.3M
3. Profitability & Quality STRR
Gross Margin 16.1% 8.2%
Operating Margin -3.2% -2.6%
Net Profit Margin -3.7% -4.3%
Return on Equity (ROE) -30.4% -18.2%
4. Balance Sheet & Cash Flow HHS
Cash Generation (TTM) -$4.5M -$11M
Cash Flow Margin -2.9% -5.2%
Net Cash / Leverage $17M Net Debt (1.10x D/E) $19M Net Debt (0.44x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HHS
OpEx & R&D Intensity 19.3% of Rev ($30M) 10.8% of Rev ($23M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Conglomerates Operator Staffing & Employment Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HHS (4) vs STRR (5)
Institutional Metric HHS STRR Criterion Row Edge
Market Capitalization
Scale
$30.0M $37.3M Larger Scale Tie
Trailing P/E Ratio
Valuation
14.3x 10.6x Lower Multiple STRR
Forward P/E Ratio
Valuation
14.3x 8.8x Lower Multiple STRR
Revenue Growth (YoY)
Growth
-1.7% +54.6% Higher Growth STRR
Operating Margin (TTM)
Profitability
-3.2% -2.6% Higher Margin STRR
Net Profit Margin
Profitability
-3.7% -4.3% Higher Margin HHS
Return on Equity (ROE)
Capital Efficiency
-30.4% -18.2% Higher ROE STRR
52-Week Range Position
Momentum
69% ($2–$5) 38% ($9–$12) Stronger Trend HHS
Beta / 30D Volatility
Risk Regime
0.49β · 46% Vol 0.12β · 48% Vol Lower Realized Risk HHS
Unified Institutional Score
Composite Signal
61.8 / 100 (BUY) 47.5 / 100 (HOLD) Higher Composite HHS
Trailing 12M Revenue (USD)
Operating Scale
$155M $210M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.1% 8.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.19x PEG · 0.3x EV/Rev 2.03x PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.5M ($17M Net Debt (1.10x D/E)) -$11M ($19M Net Debt (0.44x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon STRR +10.8 pp
HHS: -10.49% · STRR: +0.31%
3M Horizon HHS +66.28 pp
HHS: +54.22% · STRR: -12.06%
6M Horizon HHS +37.24 pp
HHS: +38.68% · STRR: +1.44%
1Y Horizon HHS +41.23 pp
HHS: +31.51% · STRR: -9.72%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period HHS Revenue STRR Revenue HHS Op. Margin STRR Op. Margin Margin Leader
FY2018 $280M $70M -9.1% -7.8% STRR
FY2019 $220M $90M -9.9% -1.8% STRR
FY2020 $180M $100M -6.0% -2.6% STRR
FY2021 $190M $170M 3.9% 2.6% HHS
FY2022 $210M $200M 7.3% 4.6% HHS
FY2023 $190M $160M 1.8% 0.9% HHS
FY2024 $190M $140M 1.1% -2.7% HHS
FY2025 $160M $170M 0.2% -2.1% HHS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
STRR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact STRR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HHS Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $30.0M market capitalization and -3.2% operating margin.
OpEx & R&D Reinvestment 19.3% of Rev ($30M)
90D Engineering Disclosures 0 Published
STRR Moat Profile Cyclical / Execution-Driven Positioning
Staffing & Employment Services Operator
Competes within the Staffing & Employment Services value chain with $37.3M market capitalization and -2.6% operating margin.
OpEx & R&D Reinvestment 10.8% of Rev ($23M)
90D Engineering Disclosures 0 Published

Investor FAQ HHS vs STRR Key Questions & Quantitative Answers

As of Nov 16, 2026, Star Equity Holdings, Inc. (STRR) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas STRR carries 47.5/100 (HOLD) at $9.84 (8.8x Forward P/E, -2.6% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. STRR 47.5/100 HOLD), STRR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-2.6% vs. -3.2% operating margin) and revenue trajectory (+54.6% vs. -1.7% YoY).

STRR leads the Growth & Scale pillar: HHS posts -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin), compared with STRR at +54.6% YoY revenue growth and -21.6% YoY earnings growth on $210M TTM revenue (8.2% gross margin, -2.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HHS cumulative revenue shifted -42.9% while STRR shifted +142.9%. In operating R&D and SG&A reinvestment, HHS deploys 19.3% of Rev ($30M) (0 90-day corporate R&D disclosures) versus 10.8% of Rev ($23M) (0 disclosures) for STRR.

STRR screens cheaper on headline valuation multiples. HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin), whereas STRR trades at 8.8x Forward P/E, 10.6x Trailing P/E, 2.03x PEG, and 0.3x EV/Revenue (-5.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HHS (-30.4% ROE) versus STRR (-18.2% ROE) capital efficiency.

In options market volatility and institutional positioning, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk). By comparison, STRR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.12β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.